Table 2.
Odds Ratio | 95% CI | P | |
---|---|---|---|
| |||
Bisphosphonates use: yes v. no | 2.18 | 0.90 to 5.24 | 0.08 |
Age: ≥ 50 versus < 50 | 0.66 | 0.48 to 0.92 | 0.015 |
Stage: III vs I/II | 0.69 | 0.5 to 0.96 | 0.026 |
Grade: III vs I/II | 3.80 | 2.37 to 6.07 | <.001 |
Subtype: HER2 positive vs Hormone positive | 3.02 | 1.97 to 4.64 | <.001 |
Subtype: Triple negative vs Hormone positive | 2.66 | 1.8 to 3.93 | 0.011 |
LVI: positive vs negative | 0.38 | 0.26 to 0.57 | <.001 |
BMI: overweight vs normal | 0.69 | 0.46 to 1.04 | 0.022 |
BMI: obese vs normal | 1.09 | 0.75 to 1.59 | 0.10 |
pCR = pathologic complete response; HER2 = human epidermal growth factor receptor 2; LVI = lymphovascular invasion; BMI = body mass index; CI = confidence interval.